Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,233 | 46,466 | 14,599 | 13,718 | 16,532 |
| TOTAL | $41,913 | $47,245 | $15,561 | $13,944 | $16,927 |
| Non-Current Assets | |||||
| PPE Net | 64 | 54 | 60 | 65 | 71 |
| Other Non-Current Assets | 313 | 313 | 312 | 312 | 312 |
| TOTAL | $377 | $367 | $372 | $377 | $383 |
| Total Assets | $42,290 | $47,612 | $15,933 | $14,321 | $17,310 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 935 | 2,941 | 714 | 641 | 1,196 |
| Accrued Expenses | 2,157 | 2,356 | 2,051 | 2,040 | 1,972 |
| TOTAL | $3,092 | $5,297 | $2,764 | $2,681 | $3,168 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 727 | 727 | 727 | 727 | 727 |
| TOTAL | $727 | $727 | $727 | $727 | $727 |
| Total Liabilities | $3,820 | $6,024 | $3,492 | $3,409 | $3,895 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,591 | 12,383 | 11,452 | 6,311 | 5,825 |
| Common Shares | 12 | 12 | 8 | 6 | 6 |
| Retained earnings | -340,521 | -336,929 | -333,641 | -331,186 | -328,213 |
| Other shareholders' equity | -10,618 | -11,126 | -10,635 | -10,630 | -10,628 |
| TOTAL | $38,470 | $41,588 | $12,442 | $10,913 | $13,415 |
| Total Liabilities And Equity | $42,290 | $47,612 | $15,933 | $14,321 | $17,310 |